These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 8744680
1. Reactivity of monoclonal antibodies OK-CLL (anti-CD5) with peripheral blood cells of patients with B cell lymphoproliferative disorders. Milosević D, Marinković M, Jelić S, Colović M, Spuzić I. Arch Immunol Ther Exp (Warsz); 1995; 43(1):23-9. PubMed ID: 8744680 [Abstract] [Full Text] [Related]
2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Cabezudo E, Carrara P, Morilla R, Matutes E. Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919 [Abstract] [Full Text] [Related]
5. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections. Dorfman DM, Shahsafaei A. Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947 [Abstract] [Full Text] [Related]
6. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J. Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002 [Abstract] [Full Text] [Related]
7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B. Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [Abstract] [Full Text] [Related]
10. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages. Eksioğlu-Demiralp E, Alpdoğan O, Aktan M, Firatli T, Oztürk A, Budak T, Bayik M, Akoğlu T. Leukemia; 1996 Aug; 10(8):1331-9. PubMed ID: 8709639 [Abstract] [Full Text] [Related]
15. The absence of correlation between immunoregulatory T cells and induced lymphoproliferative response in treated B-chronic lymphocytic leukemia patients. Milosević D, Marinković M, Colović M, Jelić S. Panminerva Med; 1999 Jun; 41(2):93-7. PubMed ID: 10479904 [Abstract] [Full Text] [Related]
19. Surface-antigen expression profiling (SEP) in B-cell chronic lymphocytic leukemia (B-CLL): Identification of markers with prognostic relevance. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, Attadia V, Rupolo M, Buccisano F, Steffan A, Del Poeta G, Pucillo C, Colombatti A, Campanini R, Gattei V. J Immunol Methods; 2005 Oct 20; 305(1):20-32. PubMed ID: 16198366 [Abstract] [Full Text] [Related]
20. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders. Lúcio PJ, Faria MT, Pinto AM, da Silva MR, Correia Júnior ME, da Costa RJ, Parreira AB. Haematologica; 1998 Feb 20; 83(2):104-11. PubMed ID: 9549920 [Abstract] [Full Text] [Related] Page: [Next] [New Search]